Comparing two operators versus one for GlideScope intubation
A Two-Operator Technique for GlideScope-Assisted Endotracheal Intubation: Does It Yield a Similar Success Rate? A Randomized Controlled Trial
This study is testing if using two operators instead of one for GlideScope intubation can help adults have a better and safer experience during the procedure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 428 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | American University of Beirut Medical Center Academic / other |
| Locations | 1 site (Beirut) |
| Trial ID | NCT06727513 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a two-operator technique for GlideScope-assisted endotracheal intubation compared to a single-operator approach. It will assess the first attempt success rate, time to intubate, and the occurrence of adverse events such as airway trauma and oxyhemoglobin desaturation. A total of 428 adult patients will be enrolled and randomly assigned to either the single or double operator group, with stratification based on predictors of difficult intubation. The study seeks to determine if the two-operator method improves outcomes in difficult intubation scenarios.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older, classified as ASA Class I to III, undergoing elective procedures requiring orotracheal intubation.
Not a fit: Patients with ASA Class IV or V, those requiring emergency procedures, or those with specific airway pathologies will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the success rate of intubation in patients with difficult airways, leading to safer anesthesia practices.
How similar studies have performed: While the two-operator technique is a novel approach in this context, similar studies have shown promising results in improving intubation success rates.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult population ≥ 18 years of age * American Society of Anesthesiologists (ASA) Class I to III * Elective procedures * Patients requiring orotracheal intubation with a single-lumen tube under general anesthesia Exclusion Criteria: * American Society of Anesthesiologists (ASA) IV or V * Emergency procedures * Patients who require awake or asleep fiberoptic intubation * Patients who require nasal intubation * Patients who require double-lumen endotracheal tube (ETT) * Patients who are already intubated * Patients who require rapid sequence induction (uncontrolled Gastroesophageal reflux disease (GERD), hiatal hernia, full stomach) * Patients with an oropharyngeal/laryngeal pathology (tumor, abscess) * Patients with maxillary or mandibular fracture
Where this trial is running
Beirut
- American University of Beirut Medical Center — Beirut, Lebanon (Recruiting)
Study contacts
- Principal investigator: Roland Kaddoum, MD — American University of Beirut Medical Center
- Study coordinator: Roland Kaddoum, MD
- Email: rk16@aub.edu.lb
- Phone: 01350000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.